AZN congressional trades
AstraZeneca PLC - American Depositary Shares (AZN) appears in 16 congressional disclosure rows from 6 members of Congress in 2025–2026 periodic reports: 11 purchases and 5 sales, with trade dates from Oct 29, 2024 to Mar 31, 2026. Lisa McClain reported the most, with 6 rows. The median gap between trade date and filing date is 27 days, and 5 trades were reported more than 45 days after it happened.
Rows keep the disclosed owner and amount range. This is a record of reported transactions, not a live AZN portfolio or a trading signal.
- 16
- 6
- 11 / 5
- $30K – $275K
- sum of reported ranges
- 2026-03-31
Verified AZN congressional disclosures
Parsed from official House Clerk and Senate eFD filings. This snapshot contains 11 purchases and 5 sales. Reported owners: Self, Spouse. Transaction dates run from 2024-10-29 to 2026-03-31.
| Politician | Trade date | Asset | Type | Owner | Amount | Filing |
|---|---|---|---|---|---|---|
| Alan Armstrong | AstraZeneca PLC Ordinary Shares | Purchase | Self | $1,001 - $15,000 | #fda235b3-bad7-4637-8fa1-053f354d929c Filed 2026-07-21 | |
| Alan Armstrong | AstraZeneca PLC Ordinary Shares | Purchase | Self | $15,001 - $50,000 | #fda235b3-bad7-4637-8fa1-053f354d929c Filed 2026-07-21 | |
| Gilbert Cisneros | AstraZeneca PLC - American Depositary Shares | Purchase | Self | $1,001 - $15,000 | #20033762 Filed 2026-01-12 | |
| Julia Letlow | AstraZeneca PLC - American Depositary Shares | Purchase | Self | $1,001 - $15,000 | #20030977 Filed 2026-01-13 | |
| Gilbert Cisneros | AstraZeneca PLC - American Depositary Shares | Purchase | Self | $1,001 - $15,000 | #20033619 Filed 2025-12-15 | |
| Lisa McClain | AstraZeneca PLC - American Depositary Shares | Sale | Spouse | $1,001 - $15,000 | #20033446 Filed 2025-11-21 | |
| Lisa McClain | AstraZeneca PLC - American Depositary Shares | Purchase | Spouse | $1,001 - $15,000 | #20033446 Filed 2025-11-21 | |
| Lisa McClain | AstraZeneca PLC - American Depositary Shares | Sale | Spouse | $1,001 - $15,000 | #20033446 Filed 2025-11-21 | |
| Gilbert Cisneros | AstraZeneca PLC - American Depositary Shares | Purchase | Self | $1,001 - $15,000 | #20033455 Filed 2025-11-18 | |
| Valerie Hoyle | AstraZeneca PLC - American Depositary Shares | Sale | Spouse | $1,001 - $15,000 | #20032211 Filed 2025-10-10 | |
| Lisa McClain | AstraZeneca PLC - American Depositary Shares | Purchase | Spouse | $1,001 - $15,000 | #20030891 Filed 2025-08-13 | |
| Lisa McClain | AstraZeneca PLC - American Depositary Shares | Sale | Spouse | $1,001 - $15,000 | #20030891 Filed 2025-08-13 | |
| Lisa McClain | AstraZeneca PLC - American Depositary Shares | Purchase | Spouse | $1,001 - $15,000 | #20030891 Filed 2025-08-13 | |
| Bruce Westerman | AstraZeneca PLC - American Depositary Shares | Sale | Self | $1,001 - $15,000 | #20030332 Filed 2025-05-12 | |
| Bruce Westerman | AstraZeneca PLC - American Depositary Shares | Purchase | Self | $1,001 - $15,000 | #20030146 Filed 2025-04-16 | |
| Valerie Hoyle | AstraZeneca PLC - American Depositary Shares | Purchase | Spouse | $1,001 - $15,000 | #20032070 Filed 2025-09-12 |
A filing can describe the member, a spouse, a dependent, or a joint asset. Amounts are statutory ranges, not execution prices. See how to read congressional stock-trade disclosures before treating a delayed row as a trading signal.
AZN disclosures by member
| Member | Rows | Buys | Sells | Last trade |
|---|---|---|---|---|
| Lisa McClain's AZN trades | 6 | 3 | 3 | 2025-10-31 |
| Gilbert Cisneros's AZN trades | 3 | 3 | 0 | 2025-12-18 |
| Alan Armstrong | 2 | 2 | 0 | 2026-03-31 |
| Bruce Westerman | 2 | 1 | 1 | 2025-04-21 |
| Valerie Hoyle | 2 | 1 | 1 | 2025-09-23 |
| Julia Letlow | 1 | 1 | 0 | 2025-12-08 |
How long disclosure took
Days from trade date to filing date for 16 rows. The STOCK Act allows 30 days from notification and no more than 45 days from the trade. A late row is a timing fact, not evidence of wrongdoing.
- 0–15 days
- 0
- 16–30 days
- 9
- 31–45 days
- 2
- Over 45 days
- 5
- Median / longest
- 27d / 318d
Source documents
11 House Clerk and Senate eFD periodic transaction reports, newest first. Each link opens the official filing.
- #fda235b3-bad7-4637-8fa1-053f354d929cFiled 2026-07-21 · 2 rows
- #20030977Filed 2026-01-13 · 1 row
- #20033762Filed 2026-01-12 · 1 row
- #20033619Filed 2025-12-15 · 1 row
- #20033446Filed 2025-11-21 · 3 rows
- #20033455Filed 2025-11-18 · 1 row
- #20032211Filed 2025-10-10 · 1 row
- #20032070Filed 2025-09-12 · 1 row
- #20030891Filed 2025-08-13 · 3 rows
- #20030332Filed 2025-05-12 · 1 row
- #20030146Filed 2025-04-16 · 1 row
What AZN filings don’t tell you
A disclosure row records a trade date, an amount bracket, and who owned the asset. It does not say why the trade was made, whether the position is still held, or anything about the business behind the ticker: revenue trends, margins, balance-sheet risk, or valuation. Those answers are in company filings, not congressional ones.
To work through a company yourself, use our stock research checklist. Members get the full version of that work: one sourced investment call a month, with the numbers and the risks that would change the view.
Members-only research
What members are reading this month
- NVIDIA’s growth has a financing bill
Sales up about 18% on the prior quarter, receivables up about 55%, supply commitments at $279 billion. What NVIDIA’s financing bill means for the price you pay.
- Citadel bought the AI fire sale. The seller had run out of time.
Up 439% in the first half, down about 67% in July: how an AI hedge fund ended up selling a roughly $16 billion stock book to Citadel at a discount.
The thesis, the numbers behind it, and what would break it. Full access is $39 a month.
Read the full researchRelated research
AZN congressional trades: FAQ
Who in Congress traded AZN?
House Clerk and Senate eFD periodic reports for 2025 and 2026 contain 16 verified AZN rows from 6 members: Alan Armstrong, Bruce Westerman, Gilbert Cisneros, Julia Letlow, and 2 other members. Image-only filings are excluded, and this is not a live brokerage statement.
Does this page show current AZN holdings?
No. STOCK Act filings disclose reportable transactions after the fact, usually within 45 days, as amount ranges and owners. They do not prove a current position, an exact share count, or why the trade happened.
Why are AZN amounts shown as ranges?
Congressional periodic transaction reports use statutory value bands such as $1,001 - $15,000; $15,001 - $50,000. Yield Theory keeps those ranges instead of inventing a midpoint, exact trade size, or return.
How complete is AZN congressional-trade coverage?
This snapshot covers every machine-readable House and Senate periodic transaction report for 2025 and 2026 (178 members). Image-only House filings and paper Senate filings are not included, so missing rows are not proof that no other lawmaker traded AZN.
Yield Theory is not affiliated with any elected official. This page uses the 2025–2026 House Clerk and Senate eFD periodic report snapshot generated 2026-11-03. It is not a complete lifetime portfolio, a performance track record, or investment advice.
A disclosure is not a thesis.
This page shows who reported AZN and in what range. Membership is the monthly sourced call, plus a five-minute check when the evidence moves. $39/month or $249/year.
Members-only research
$39/mo or $249/yr · cancel future renewals anytime · sources included